Severe Sepsis Clinical Trial
— EIDECSOfficial title:
A Time-series Intervention Analysis of End-of-life Decision-making in Patients With Sepsis-related Organ Failure
| Verified date | August 2017 |
| Source | Center for Sepsis Control and Care, Germany |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Interventional |
The care of patients with sepsis-related organ failure on the intensive care unit (ICU) often
includes end-of-life decision (EOL-D) and communication of such decisions to relatives. This
increases the psychological burden for caregiver and relatives.
The investigators intend to assess the prevalence and impact of EOL-D on ICU care-givers and
relatives ("before") and to use this data to develop and implement standard operating
procedures (SOPs) for improved decision-making and communication of these decisions
("after").
The hypothesis is that an improved communication strategy will reduce symptoms of burnout in
caregivers and symptoms of anxiety and depression in relatives.
| Status | Completed |
| Enrollment | 174 |
| Est. completion date | September 30, 2014 |
| Est. primary completion date | September 30, 2014 |
| Accepts healthy volunteers | No |
| Gender | All |
| Age group | N/A and older |
| Eligibility |
Staff: Inclusion Criteria: - all physicians and nursing staff who treat patients with sepsis-related organ failure on participating ICUs who consent to participate Exclusion Criteria: - Decline to participate Relatives: - Relatives of patients with sepsis-related organ failure and EOL-D who consent to participate Exclusion Criteria: - Decline to participate |
| Country | Name | City | State |
|---|---|---|---|
| Germany | Jena University Hospital | Jena | Thuringia |
| Lead Sponsor | Collaborator |
|---|---|
| Center for Sepsis Control and Care, Germany | German Federal Ministry of Education and Research |
Germany,
Embriaco N, Papazian L, Kentish-Barnes N, Pochard F, Azoulay E. Burnout syndrome among critical care healthcare workers. Curr Opin Crit Care. 2007 Oct;13(5):482-8. Review. — View Citation
Hartog CS, Schwarzkopf D, Riedemann NC, Pfeifer R, Guenther A, Egerland K, Sprung CL, Hoyer H, Gensichen J, Reinhart K. End-of-life care in the intensive care unit: a patient-based questionnaire of intensive care unit staff perception and relatives' psych — View Citation
Lautrette A, Darmon M, Megarbane B, Joly LM, Chevret S, Adrie C, Barnoud D, Bleichner G, Bruel C, Choukroun G, Curtis JR, Fieux F, Galliot R, Garrouste-Orgeas M, Georges H, Goldgran-Toledano D, Jourdain M, Loubert G, Reignier J, Saidi F, Souweine B, Vincent F, Barnes NK, Pochard F, Schlemmer B, Azoulay E. A communication strategy and brochure for relatives of patients dying in the ICU. N Engl J Med. 2007 Feb 1;356(5):469-78. Erratum in: N Engl J Med. 2007 Jul 12;357(2):203. — View Citation
Schwarzkopf D, Westermann I, Skupin H, Riedemann NC, Reinhart K, Pfeifer R, Fritzenwanger M, Günther A, Witte OW, Hartog CS. A novel questionnaire to measure staff perception of end-of-life decision making in the intensive care unit--development and psych — View Citation
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Symptoms of burnout by MBI score in ICU caregivers | once during observation period (1 year) | ||
| Primary | Symptoms of post-traumatic stress disorder by IES and HADS scores in relatives at 90 days | once during observation period (1 year) | ||
| Secondary | Psychological symptoms by IES, HADS or MBI subscales in caregivers or relatives, respectively | once during the observation period (1 year) | ||
| Secondary | Characteristics of patients with and without end-of-life decisions (EOL-D) including time periods (time until EOL-D, time between EOL-D until death or discharge) and 28-day and 90-day mortality rates | until death or discharge from the ICU | ||
| Secondary | Prevalence and characteristics of EOL-D | until death or discharge from the ICU | ||
| Secondary | Prevalence and characteristics of patients' advance directives | until death or discharge from the ICU | ||
| Secondary | characteristics of EOL-D communication with relatives | ICU stay | ||
| Secondary | Prevalence of request for "Ethik Konsil" (counseling by an external ethical review board) | until death or discharge from the ICU | ||
| Secondary | direct costs of treatment of survivors and non-survivors | until death or discharge from the ICU |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04804306 -
Sepsis Post Market Clinical Utility Simple Endpoint Study - HUMC
|
||
| Completed |
NCT04227652 -
Control of Fever in Septic Patients
|
N/A | |
| Recruiting |
NCT04005001 -
Machine Learning Sepsis Alert Notification Using Clinical Data
|
Phase 2 | |
| Recruiting |
NCT02899143 -
Short-course Antimicrobial Therapy in Sepsis
|
Phase 2 | |
| Completed |
NCT02539147 -
Characterization of Non-canonical Way in Inflammasome Monocytes of Patients With Severe Sepsis
|
N/A | |
| Completed |
NCT01929772 -
German Lactat Clearance in Severe Sepsis
|
N/A | |
| Completed |
NCT01932814 -
Acute Kidney Injury in Septic Critically Ill Patients : Are Aminoglycosides Really Harmful?
|
N/A | |
| Completed |
NCT01449721 -
Preemptive Resuscitation for Eradication of Septic Shock
|
N/A | |
| Active, not recruiting |
NCT01162109 -
Zinc Therapy in Critical Illness
|
Phase 1 | |
| Not yet recruiting |
NCT01211899 -
4G/5G Polymorphism of Plasminogen Activator Inhibitor-1 Gene and Disseminated Intravascular Coagulation in Severe Sepsis and Septic Shock
|
N/A | |
| Completed |
NCT00934011 -
Use of Inflammatory Biomarkers to Guide Antibiotic Therapy in Patients With Severe Infections
|
N/A | |
| Recruiting |
NCT00335907 -
Protocol-driven Hemodynamic Support for Patients With Septic Shock
|
N/A | |
| Completed |
NCT00463645 -
Investigation of Correlation Between Interstitial and Arterial Blood Glucose Concentrations in Septic Patients
|
N/A | |
| Completed |
NCT02361528 -
GM-CSF to Decrease ICU Acquired Infections
|
Phase 3 | |
| Completed |
NCT02734550 -
(1,3)-β-D-glucan Based Diagnosis of Invasive Candida Infection in Sepsis
|
N/A | |
| Completed |
NCT02973243 -
The Vital Signs to Identify, Target, and Assess Level (VITAL) Care Study III
|
N/A | |
| Terminated |
NCT03895853 -
Early Metabolic Resuscitation for Septic Shock
|
Phase 2 | |
| Completed |
NCT01945983 -
Early Use of Norepinephrine in Septic Shock Resuscitation
|
N/A | |
| Completed |
NCT01598831 -
Phase 3 Safety and Efficacy Study of ART-123 in Subjects With Severe Sepsis and Coagulopathy
|
Phase 3 | |
| Enrolling by invitation |
NCT02258984 -
Can the Venus 1000 Help Clinicians Treat Patients With Severe Sepsis or Acute Heart Failure? The CVP Trial
|
N/A |